Preclinical evaluation of an innovative anti-TAM approach based on zoledronate-loaded erythrocytes

Raffaella Sabatino1, Serafina Battistelli2, Mauro Magnani1

  • 1Department of Biomolecular Sciences, Section of Biochemistry and Molecular Biology, University of Urbino "Carlo Bo", via A. Saffi 2, 61029, Urbino, PU, Italy.

Insights

Zoledronate-loaded red blood cells (RBCs) effectively reduce tumor-associated macrophages (TAMs) and inhibit tumor growth in mice. This RBC-based drug delivery system shows promise for cancer therapy by targeting TAMs.

Area of Science:

  • Immunology
  • Oncology
  • Pharmacology

Background:

  • Tumor-associated macrophages (TAMs) play a crucial role in promoting tumor growth, metastasis, and drug resistance.
  • Targeting TAMs is a promising strategy for cancer therapy.
  • Zoledronate, a bisphosphonate, has demonstrated effects on TAM functions.

Purpose of the Study:

  • To evaluate the anti-tumor effects of zoledronate encapsulated in red blood cells (RBCs).
  • To investigate the impact of single and repeated administrations of zoledronate-loaded RBCs on TAMs and tumor growth in a murine mammary carcinoma model.

Main Methods:

  • Administration of zoledronate-loaded RBCs and free zoledronate to mice with mammary carcinoma.
  • Quantification of TAMs in tumor mass.
  • Assessment of tumor growth rate.
  • Evaluation of spleen macrophage depletion.
  • Analysis of Th1 cytotoxic response via IgG2a/IgG1 ratio.

Main Results:

  • Zoledronate-loaded RBCs significantly reduced TAMs in the tumor microenvironment, unlike free zoledronate.
  • Repeated administration of zoledronate-loaded RBCs significantly reduced tumor growth rate.
  • The anti-tumor effect was associated with early depletion of spleen macrophages.
  • A Th1-biased cytotoxic response was observed in mice treated with zoledronate-loaded RBCs.

Conclusions:

  • Zoledronate-loaded RBCs are effective in reducing TAMs and inhibiting tumor growth.
  • This drug delivery system shows potential as a therapeutic strategy for cancer by indirectly depleting TAMs.
  • The findings underscore the importance of macrophages in cancer progression and highlight the suitability of zoledronate-loaded RBCs for cancer treatment.

Related Concept Videos

Lifecycle of Erythrocytes01:22

Lifecycle of Erythrocytes

Erythrocytes, also known as red blood cells, constantly move through blood capillaries. As a result, they damage their plasma membrane due to the continuous friction. Typically, after 100 to 120 days, erythrocytes become rigid and fragile as they wear out. As they pass through small vessels in the spleen and liver, they can get trapped and break apart into fragments.
The resident phagocytic macrophages deal with these damaged cells by engulfing them and separating their globin and heme groups....
5.3K
Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
2.3K
Structure and Function of Erythrocytes01:29

Structure and Function of Erythrocytes

There are between 4.2 and 6 million erythrocytes, also known as red blood cells, in every microliter of blood. These cells are small, flattened biconcave discs with centers that are depressed.
The erythrocyte plasma membrane is associated with proteins such as spectrin, which forms a flexible cytoplasmic meshwork. This meshwork allows erythrocytes to twist, turn, become cup-shaped, and regain their biconcave shape as they pass through narrow capillaries. Additionally, erythrocytes can form...
6.0K
Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
6.0K
Impact Loading01:19

Impact Loading

Impact loading occurs when a moving object collides with a stationary structure, such as a rod with a uniform cross-sectional area fixed at one end. Under these conditions, the rod absorbs the kinetic energy from the striking object, leading to deformation and subsequent stress development. As the rod returns to its original position and reaches maximum stress, the absorbed energy, initially manifested as kinetic energy, transforms entirely into strain energy.
In cases of elastic deformation,...
708
Self-Evaluation: Self-Enhancement and Self-Verification03:00

Self-Evaluation: Self-Enhancement and Self-Verification

Social psychologists have documented that feeling good about ourselves and maintaining positive self-esteem is a powerful motivator of human behavior (Tavris & Aronson, 2008). In the United States, members of the predominant culture typically think very highly of themselves and view themselves as good people who are above average on many desirable traits (Ehrlinger, Gilovich, & Ross, 2005). Often, our behavior, attitudes, and beliefs are affected when we experience a threat to our...
5.8K